Cross-source evidence timeline
Insulin glargine-aldy research timeline
Follow 4 selected, directly cited source records from April 29, 2026 through July 8, 2026. This timeline joins source lanes for navigation; it does not infer that one record confirms another.
Source year
2026
Regulatory
Insulin glargine-aldy DailyMed SPL version 5↗
DailyMed lists Structured Product Labeling version 5 for the reviewed Insulin glargine-aldy label family with a published date of 2026-07-08. PeptideScanner retained the exact versioned ZIP byte count and SHA-256 receipt without republishing its contents.↗
Added to PeptideScanner August 22, 2026Regulatory
Insulin glargine-aldy DailyMed SPL version 2↗
DailyMed lists Structured Product Labeling version 2 for the reviewed Insulin glargine-aldy label family with a published date of 2026-06-05. PeptideScanner retained the exact versioned ZIP byte count and SHA-256 receipt without republishing its contents.↗
Added to PeptideScanner August 22, 2026Regulatory
Insulin glargine-aldy DailyMed SPL version 1↗
DailyMed lists Structured Product Labeling version 1 for the reviewed Insulin glargine-aldy label family with a published date of 2026-06-02. PeptideScanner retained the exact versioned ZIP byte count and SHA-256 receipt without republishing its contents.↗
Added to PeptideScanner August 22, 2026Regulatory
Drugs@FDA application BLA761412↗
The official Drugs@FDA dataset lists original submission 1 for BLA 761412 with status AP dated 2026-04-29, and names insulin glargine-aldy among the application record's active ingredients.↗
Added to PeptideScanner August 14, 2026